Skip to content

A Clinical Trial to Assess the Safety, Tolerability and Efficacy of the Baby Care Products.

A Clinical Trial to Assess the Dermatological and Ophthalmological Safety, Tolerability and Efficacy of the Baby Care Products in Healthy Neonates, Babies and Young Children. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107296
Enrollment
105
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Head-to-Toe Baby Wash: Apply to the scalp, face and whole-body during bath for 7 days. Intervention2: Baby Wet Wipes: Apply to the face whole body and diaper area during diaper changes

Sponsors

Mother Sparsh Baby Care Pvt. Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects with all skin types (dry, normal, oily, combination, sensitive, and eczema-prone), as assessed by a dermatologist, and in good general health based on medical history and physical examination. 2. Subject wearing diaper at least for 12 hours per day. 3. Parent or legal representative (preferably the mother) provides written informed consent and agrees to attend follow-ups and comply with the study protocol. 4. Subject must not participate in any other clinical study during this study.

Exclusion criteria

Exclusion criteria: 1.Subject above 6 years of age. 2. Subject with known allergy or chronic illness that may affect cutaneous assessment or require medical attention. 3. Subjects parent/legal representative not willing to stop use of other lotions during the study period, or the subject is on any systemic medication. 4. Subject with birth defects, chromosomal/metabolic anomalies, or significant dermatological diseases/conditions (e.g., atopy, psoriasis, vitiligo, porphyria, chronic urticaria, sunburn, rashes) that may alter skin appearance or physiological response. 5. Subject judged by the investigator to be inappropriate for this trial.

Design outcomes

Primary

MeasureTime frame
Mean change in overall scalp, hair, and skin condition, ocular safety assessed by parents, investigators, and ophthalmologist.Timepoint: Baseline and End of Treatment

Secondary

MeasureTime frame
Mean change in the scores of safety and tolerability scales of test products by the investigator and also basis parent s daily observation record.Timepoint: Baseline and End of Treatment

Countries

India

Contacts

Public ContactJestin V Thomas

Leads Clinical Research and Bio Services Pvt. Ltd.

jestin.leadsclinbio@gmail.com9845125293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026